Ownership history in Eversept Partners, LP · 11 quarters on record
This page tracks every 13F SEC filing in which Eversept Partners, LP reported a position in SUTRO BIOPHARMA INC (STRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 193,571 | -2,097,742 | -91.6% | 0.11% | $2.2M | $11.57 |
| 2025 Q3 | REDUCED | 2,291,313 | -948 | -0.0% | 0.14% | $2.0M | $8.70 |
| 2025 Q2 | UNCHANGED | 2,292,261 | — | 0% | 0.15% | $1.6M | $7.10 |
| 2025 Q1 | ADDED | 2,292,261 | +1,597,853 | +230.1% | 0.15% | $1.5M | $6.50 |
| 2024 Q4 | REDUCED | 694,408 | -1,147,581 | -62.3% | 0.11% | $1.3M | $18.40 |
| 2024 Q3 | ADDED | 1,841,989 | +102,860 | +5.9% | 0.44% | $6.4M | $34.60 |
| 2024 Q2 | ADDED | 1,739,129 | +647,710 | +59.3% | 0.35% | $5.1M | $29.30 |
| 2024 Q1 | ADDED | 1,091,419 | +34,958 | +3.3% | 0.41% | $6.2M | $56.50 |
| 2023 Q4 | ADDED | 1,056,461 | +286,823 | +37.3% | 0.40% | $4.5M | $42.90 |
| 2023 Q3 | ADDED | 769,638 | +21,726 | +2.9% | 0.23% | $2.7M | $34.70 |
As of 2025 Q4 — sorted by position size